We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy These 3 Healthcare Mutual Funds for a Steady Portfolio
Read MoreHide Full Article
Investors often rely on the healthcare sector to safeguard their investments. This is because healthcare services do not see their demand varying much with market conditions and thus offer sufficient protection to the capital invested.
Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate stable cash flows, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Advisor Health Care Fund Class M aims for capital growth. FACTX invests the majority of its assets in common stocks of companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. Fidelity Advisor Health Care Fund Class M invests in both U.S. as well as non-U.S. issuers.
Fidelity Advisor Health Care Fund Class M has three-year annualized returns of 19.6%. Edward Yoon has been the fund manager of FACTX since 2008.
Fidelity Select Medical Technology and Devices Portfolio fund aims for capital growth. It invests the majority of its assets in companies engaged in activities such as research, manufacturing, supply and sale of medical equipment and related technologies. FSMEX invests in common stocks and in U.S. and non-U.S. issuers.
Fidelity Select Medical Technology and Devices Portfolio has three-year annualized returns of 28%. FSMEX has an expense ratio of 0.70% compared with the category average of 1.03%.
Fidelity Select Health Care Portfolio is a non-diversified fund that aims for capital appreciation. FSPHX invests the majority of its assets in common stocks of companies engaged in the designing, manufacturing, or sale of products or services related to healthcare or medicine.
Fidelity Select Health Care Portfolio has three-year annualized returns of 22.2%. As of the end of November 2021, FSPHX held 72 issues with 13.9% of its assets invested in Thermo Fisher Scientific Inc.
Image: Shutterstock
Buy These 3 Healthcare Mutual Funds for a Steady Portfolio
Investors often rely on the healthcare sector to safeguard their investments. This is because healthcare services do not see their demand varying much with market conditions and thus offer sufficient protection to the capital invested.
Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate stable cash flows, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below we share with you three top-ranked healthcare mutual funds — Fidelity Advisor Health Care Fund Class M (FACTX - Free Report) , Fidelity Select Medical Technology and Devices Portfolio (FSMEX - Free Report) and Fidelity Select Health Care Portfolio (FSPHX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Advisor Health Care Fund Class M aims for capital growth. FACTX invests the majority of its assets in common stocks of companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. Fidelity Advisor Health Care Fund Class M invests in both U.S. as well as non-U.S. issuers.
Fidelity Advisor Health Care Fund Class M has three-year annualized returns of 19.6%. Edward Yoon has been the fund manager of FACTX since 2008.
Fidelity Select Medical Technology and Devices Portfolio fund aims for capital growth. It invests the majority of its assets in companies engaged in activities such as research, manufacturing, supply and sale of medical equipment and related technologies. FSMEX invests in common stocks and in U.S. and non-U.S. issuers.
Fidelity Select Medical Technology and Devices Portfolio has three-year annualized returns of 28%. FSMEX has an expense ratio of 0.70% compared with the category average of 1.03%.
Fidelity Select Health Care Portfolio is a non-diversified fund that aims for capital appreciation. FSPHX invests the majority of its assets in common stocks of companies engaged in the designing, manufacturing, or sale of products or services related to healthcare or medicine.
Fidelity Select Health Care Portfolio has three-year annualized returns of 22.2%. As of the end of November 2021, FSPHX held 72 issues with 13.9% of its assets invested in Thermo Fisher Scientific Inc.
To view the Zacks Rank and past performance of all healthcare mutual funds, investors can click here to see the complete list of funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>